Quercetin Decreases Insulin Resistance in a Polycystic Ovary Syndrome Rat Model by Improving Inflammatory Microenvironment - PubMed (original) (raw)
. 2017 May;24(5):682-690.
doi: 10.1177/1933719116667218. Epub 2016 Sep 15.
Affiliations
- PMID: 27634381
- DOI: 10.1177/1933719116667218
Quercetin Decreases Insulin Resistance in a Polycystic Ovary Syndrome Rat Model by Improving Inflammatory Microenvironment
Zhenzhi Wang et al. Reprod Sci. 2017 May.
Abstract
Insulin resistance (IR) is a clinical feature of polycystic ovary syndrome (PCOS). Quercetin, derived from Chinese medicinal herbs such as hawthorn, has been proven practical in the management of IR in diabetes. However, whether quercetin could decrease IR in PCOS is unknown. This study aims to observe the therapeutic effect of quercetin on IR in a PCOS rat model and explore the underlying mechanism. An IR PCOS rat model was established by subcutaneous injection with dehydroepiandrosterone. The body weight, estrous cycle, and ovary morphology of the quercetin-treated rats were observed. Serum inflammatory cytokines were analyzed using enzyme-linked immunosorbent assay. In ovarian tissues, the expression of key genes involved in the inflammatory signaling pathway was detected through Western blot, real-time polymerase chain reaction, or immunohistochemistry. The nuclear translocation of nuclear factor κB (NF-κB) was also observed by immunofluorescence. The estrous cycle recovery rate of the insulin-resistant PCOS model after quercetin treatment was 58.33%. Quercetin significantly reduced the levels of blood insulin, interleukin 1β, IL-6, and tumor necrosis factor α. Quercetin also significantly decreased the granulosa cell nuclear translocation of NF-κB in the insulin-resistant PCOS rat model. The treatment inhibited the expression of inflammation-related genes, including the nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox, oxidized low-density lipoprotein, and Toll-like receptor 4, in ovarian tissue. Quercetin improved IR and demonstrated a favorable therapeutic effect on the PCOS rats. The underlying mechanism of quercetin potentially involves the inhibition of the Toll-like receptor/NF-κB signaling pathway and the improvement in the inflammatory microenvironment of the ovarian tissue of the PCOS rat model.
Keywords: TLR/NF-κB signaling pathway; inflammatory microenvironment; insulin resistance; polycystic ovary syndrome; quercetin.
Similar articles
- Ghrelin Alleviates Inflammation, Insulin Resistance, and Reproductive Abnormalities in Mice with Polycystic Ovary Syndrome via the TLR4-NF-κB Signaling Pathway.
Liu F, Wang X, Zhao M, Zhang K, Li C, Lin H, Xu L. Liu F, et al. Discov Med. 2024 May;36(184):946-958. doi: 10.24976/Discov.Med.202436184.88. Discov Med. 2024. PMID: 38798254 - Zishen Qingre Lishi Huayu Recipe May Ameliorate the Symptoms of PCOS Model Rats via Alleviating Systemic and Ovarian Inflammation.
Li X, Yi Y, Ren Y, Zhang Y, Wang CC, Liu C, Liu S, Zhan X, Yu X, Liang R. Li X, et al. Am J Reprod Immunol. 2024 Aug;92(2):e13918. doi: 10.1111/aji.13918. Am J Reprod Immunol. 2024. PMID: 39158962 - Decreased Insulin Resistance by Myo-Inositol Is Associated with Suppressed Interleukin 6/Phospho-STAT3 Signaling in a Rat Polycystic Ovary Syndrome Model.
Zhang Y, Li C, Zhang W, Zheng X, Chen X. Zhang Y, et al. J Med Food. 2020 Apr;23(4):375-387. doi: 10.1089/jmf.2019.4580. Epub 2020 Feb 11. J Med Food. 2020. PMID: 32045334 - Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
Dhindsa G, Bhatia R, Dhindsa M, Bhatia V. Dhindsa G, et al. J Postgrad Med. 2004 Apr-Jun;50(2):140-4. J Postgrad Med. 2004. PMID: 15235215 Review. - Insights on the NF-κB system in polycystic ovary syndrome, attractive therapeutic targets.
Tan W, Zhang J, Dai F, Yang D, Gu R, Tang L, Liu H, Cheng YX. Tan W, et al. Mol Cell Biochem. 2024 Mar;479(3):467-486. doi: 10.1007/s11010-023-04736-w. Epub 2023 Apr 25. Mol Cell Biochem. 2024. PMID: 37097332 Review.
Cited by
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs.
Malik S, Saeed S, Saleem A, Khan MI, Khan A, Akhtar MF. Malik S, et al. Front Endocrinol (Lausanne). 2024 Jan 11;14:1294406. doi: 10.3389/fendo.2023.1294406. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38725974 Free PMC article. Review. - Tenascin C activates the toll‑like receptor 4/NF‑κB signaling pathway to promote the development of polycystic ovary syndrome.
Wu H, Yang M, Yan C, Liu M, Wang H, Zhang W. Wu H, et al. Mol Med Rep. 2024 Jun;29(6):106. doi: 10.3892/mmr.2024.13230. Epub 2024 Apr 26. Mol Med Rep. 2024. PMID: 38666538 Free PMC article. - Effects of quercetin on polycystic ovary syndrome in animal models: a systematic review and meta-analysis.
Su P, Chen C, Pang L, Wu K, Sun Y. Su P, et al. Reprod Biol Endocrinol. 2024 Apr 18;22(1):46. doi: 10.1186/s12958-024-01220-y. Reprod Biol Endocrinol. 2024. PMID: 38637876 Free PMC article. Review. - Copper in Gynecological Diseases.
Conforti RA, Delsouc MB, Zorychta E, Telleria CM, Casais M. Conforti RA, et al. Int J Mol Sci. 2023 Dec 17;24(24):17578. doi: 10.3390/ijms242417578. Int J Mol Sci. 2023. PMID: 38139406 Free PMC article. Review. - Administration of adipose-derived mesenchymal stem cell conditioned medium improves ovarian function in polycystic ovary syndrome rats: involvement of epigenetic modifiers system.
Shafiei G, Saheli M, Ganjalikhan-Hakemi S, Haghpanah T, Nematollahi-Mahani SN. Shafiei G, et al. J Ovarian Res. 2023 Dec 15;16(1):238. doi: 10.1186/s13048-023-01317-9. J Ovarian Res. 2023. PMID: 38102694 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical